Catalyst Clinical Research announced this month that Kristin Judge is its first chief commercial officer (CCO).

She assumed the role July 29 and leads the Wilmington clinical research organization's commercial functions, according to a news release.

"Kristin has the depth of commercial experience to support Catalyst's continued growth," said Nik Morton, president and CEO of Catalyst Clinical Research, in the release. "Her experience supporting biotech and pharmaceutical customers with CRO services and life-sciences technologies will be invaluable. She has embraced Catalyst's culture and vision for a differentiated CRO, and will ensure our commercial team is best positioned to deliver strengthened sales performance and continued growth."

Prior to joining Catalyst, Judge held strategic roles at Emmes, Veeva Systems, Labcorp Drug Development, and PPD. Throughout her more than 17 years of experience, she has led inside sales, marketing and sales operations and has been a key member in numerous acquisitions and integrations, according to the release.